- Impact of General Factors on Glioma Immunotherapy
-
Huang Q, Wang D, Yao G, Wang H
- KMID: 2524547
- J Clin Neurol.
- 2022 Jan;18(1):3-13.
- doi: 10.3988/jcn.2022.18.1.3
Glioma remains the most common malignant tumor in the brain and is also the most difficult to treat. Immunotherapy achieving long-lasting tumor remission in multiple cancer types has received considerable... -
- CITED
-
- Close
- SHARE
-
- Close
